Literature DB >> 10842267

Central fatigue during isometric exercise in amyotrophic lateral sclerosis.

J A Kent-Braun1, R G Miller.   

Abstract

While both upper and lower motor neuron dysfunction may contribute to impaired muscle function in amyotrophic lateral sclerosis (ALS), the precise mechanisms of muscle fatigue have not been clarified in this disease. Therefore, the central and peripheral factors in muscle fatigue were investigated during intermittent submaximal isometric ankle dorsiflexion in 7 patients with ALS and 6 healthy control subjects. Voluntary and electrically stimulated force, central and peripheral indices of muscle activation, and intramuscular energy metabolism were measured before and during exercise. At the end of exercise, only the ALS group had an increase in the "added force" in response to a stimulus train imposed during maximal voluntary contraction, indicating significant central fatigue in ALS. In support of this conclusion, patients with ALS had less intramuscular phosphocreatine depletion and less fatigue of stimulated tetanic force during exercise compared to control. Thus, due to the central failure, there was decreased muscle activation resulting in a smaller metabolic demand and less fatigue within the muscle itself. These data demonstrate a major contribution of central factors to muscle fatigue in ALS. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10842267     DOI: 10.1002/(sici)1097-4598(200006)23:6<909::aid-mus10>3.0.co;2-v

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Central activation, muscle performance, and physical function in men infected with human immunodeficiency virus.

Authors:  Wayne B Scott; Krisann K Oursler; Leslie I Katzel; Alice S Ryan; David W Russ
Journal:  Muscle Nerve       Date:  2007-09       Impact factor: 3.217

2.  Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases.

Authors:  Alan J Russell; James J Hartman; Aaron C Hinken; Alexander R Muci; Raja Kawas; Lena Driscoll; Guillermo Godinez; Kenneth H Lee; David Marquez; William F Browne; Michael M Chen; David Clarke; Scott E Collibee; Marc Garard; Richard Hansen; Zhiheng Jia; Pu-Ping Lu; Hector Rodriguez; Khalil G Saikali; Julia Schaletzky; Vipin Vijayakumar; Daniel L Albertus; Dennis R Claflin; David J Morgans; Bradley P Morgan; Fady I Malik
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

3.  Tirasemtiv amplifies skeletal muscle response to nerve activation in humans.

Authors:  Richard Hansen; Khalil G Saikali; Willis Chou; Alan J Russell; Michael M Chen; Vipin Vijayakumar; Randall R Stoltz; Stephane Baudry; Roger M Enoka; David J Morgans; Andrew A Wolff; Fady I Malik
Journal:  Muscle Nerve       Date:  2014-12       Impact factor: 3.217

Review 4.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

Review 5.  Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions.

Authors:  Ruel Billones; Josephine K Liwang; Kierra Butler; Letitia Graves; Leorey N Saligan
Journal:  Brain Behav Immun Health       Date:  2021-05-21

Review 6.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

7.  The Effect of Three Different Strategies Based on Motor Task Performance on Neuromuscular Fatigue in Healthy Men and Men with Multiple Sclerosis.

Authors:  Laura Kyguolienė; Albertas Skurvydas; Nerijus Eimantas; Neringa Baranauskienė; Renata Balnytė; Marius Brazaitis
Journal:  Medicina (Kaunas)       Date:  2018-05-24       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.